The aims of the study were to assess the intensive care unit (ICU) outcome for critically ill patients with lung cancer, to determine the risk factors for mortality and to examine the resuscitation status on admission and during their ICU course. Data was collected from May 1999 to March 2009 for patients with lung cancer admitted to the ICU. During the study period, 51 patients with lung cancer were admitted to our ICU. The ICU and hospital mortality rates were 49 and 60%, respectively. The majority of patients were full resuscitation on admission to ICU. The resuscitation status was changed in 56% of patients during the ICU course. It is suggested that end-of-life decisions should be addressed earlier in these patients' illnesses.
Lung cancer is a major public health problem 1, 2 . It is the second most common malignancy 3 but the most common cause of cancer deaths worldwide 4, 5 . In Saudi Arabia, lung cancer is the fifth most common cancer among the male population and 15th among the female population, and the incidence of lung cancer is increasing. This is attributed to an increase in smoking among both males and females, which is a major risk factor 6 . The five-year survival rate of all patients with lung cancer is less than 15% 7, 8 . The management of lung cancer is marked by aggressive surgical procedures and intensive chemotherapy and radiation 9, 10 . This has resulted in an increasing number of patients being admitted to the intensive care unit (ICU) for the management of critical illness related to advanced underlying malignancy 9 . Survival rates in critically ill patients with cancer have improved over time, but patients admitted to the ICU with lung cancer often have acute life-threatening events, especially acute respiratory failure requiring mechanical ventilation. In addition, these patients usually exhibit cardiac and pulmonary comorbidities related to smoking 11, 12 .
An essential part of the treatment of lung cancer patients is the discussion of the prognosis of the disease, the treatment options available and the resuscitation status of the patient early in the course of the disease 9 .
The objective of this study was to measure the survival rate of critically ill patients with lung cancer admitted to the ICU. In addition, we aimed to evaluate the resuscitation status of lung cancer patients upon admission and during their ICU course.
METHODS

Setting
The study was approved by the local Institutional Review Board and conducted in a 21-bed medical and surgical ICU.
Patients
All patients with a histologically-proven diagnosis of lung cancer who were admitted to our ICU from May 1999 to March 2009 were included. We excluded postoperative lung resection patients, those younger than 16 years and brain death victims.
Measurements
Data on patients with lung cancer admitted to the ICU were prospectively collected from an ICU database. We collected the following data: baseline demographics including gender, age, body mass index, Glasgow Coma Score, lactate level and the type of admission (with pre-specified admission diagnoses). Acute Physiology and Chronic Health Evaluation II (APACHE II) scores 13 , ICU lengthof-stay (as number of calendar days in the ICU) and the hospital length-of-stay were all calculated.
Patients were followed until discharge from the hospital or death, whichever occurred first.
Statistical analysis
Continuous data were expressed as mean ± standard deviation (SD) and were compared using Student's t-test. Categorical data were expressed as a percentage and compared using the chi-square test. Statistical significance was defined as alpha less than 0.05. Statistical analysis was performed using Minitab for Windows (release 13.1).
RESULTS
Baseline characteristics
During the study period, 51 patients with lung cancer were admitted to the ICU, representing 5% of all patients with malignancies admitted to the ICU. The mean age was 58 years. Thirty-nine (76%) patients were male. Twenty-six (51%) patients had non-small-cell lung cancer and 12 (24%) had lung cancer of which the type could not be determined based on the available data. There were no significant differences between survivors and nonsurvivors regarding the type of lung cancer. The main indications for admission to the ICU are summarised in Table 2 . Respiratory diseases, mainly pneumonia, were the most common indication for admission.
Prediction of outcomes
The ICU and hospital mortality rates in our cohort were 49 and 60%, respectively. A total of 51 (73%) patients required mechanical ventilation during their stay in the ICU. Table 3 shows the comparison between survivors and non-survivors. In the univariate analyses, worse outcomes were seen in patients with a low Glasgow Coma Score, those requiring pressors or mechanical ventilation, those with higher APACHE II scores and in older patients.
Resuscitation status
The majority of patients admitted to our ICU are for full resuscitation. The resuscitation status was changed in 56% of patients, and in the nonsurvivor group 88% of patients were not-forresuscitation.
DISCUSSION
The present study showed an ICU mortality rate of 49% and an in-hospital mortality rate of 60%. The mortality rate for lung cancer patients who required mechanical ventilation was 65% higher than for the group as a whole. The predicted mortality for critically ill patients with lung cancer based on APACHE II was 54%. The present study also shows that the outcomes of lung cancer patients admitted to ICU are poor. It also confirms the findings of recent studies that showed that the outcome of critically ill patients admitted to ICU has improved significantly compared to older studies. In accordance with our findings, a study from Brazil and France 14 showed that ICU mortality was 42%, hospital mortality was 59% and the mortality rate in patients who required mechanical ventilation was 69%. Mortality increased with the presence of multi-organ failure, the severity of comorbidities and the presence of respiratory failure. In France, Boussat et al 15 showed that the ICU mortality rate of critically ill patients with lung cancer was 66% and the hospital mortality reached 75%. It is clear from the available studies that there are no absolute predictors of ICU outcomes for lung cancer patients 9 . Scoring systems such as APACHE II and the Simplified Acute Physiology Score II 16 are calculated during the first 24 hours. Most studies have shown that these systems are not useful predictors of outcome in patients with cancer, including those with lung cancer 15 .
The majority of patients admitted to our ICU are for full resuscitation. The resuscitation status was then changed in 56% of patients. This is similar to what was described in the study of Reichner et al 7 on critically ill patients with lung cancer admitted to the ICU, wherein the resuscitation status was changed in 49% of patients. This is higher than described in cancer patients admitted to ICU, in which 37% of patients received a not-forresuscitation status during their ICU stay 17 . In our study, 88% of critically ill patients with lung cancer who died were made not-for-resuscitation during their stay in the ICU. In accordance with that finding, Barbera and colleagues 18 found that 89.5% of patients with lung cancer who died in acute hospitals in Ontario had a not-for-resuscitation status. Physicians have been shown to provide cancer patients with a frank estimate of prognosis only one-third of the time, and to provide no estimate, a conscious overestimate or a conscious underestimate most of the time 17 .
Given the difficulty in determining whether critically ill lung cancer patients will benefit from an admission to the ICU, intensivists are often doubtful about the wisdom of ICU admission. Although aggressive therapy is appropriate for this patient population, subjecting them to cardiopulmonary resuscitation protocol may be futile. This issue can be dealt with by addressing the resuscitation status and initiating an end-of-life discussion early during the course of the illness 19 . Our study shows that critical care physicians are important to the discussion of the resuscitation status during the ICU course. The availability of consultants 24 hours a day in the ICU facilitates the discussion with the family about the prognosis and resuscitation status 20 .
Intensivists are important to the determination of resuscitation status in the ICU. However, the physician who has been caring for the patient should initiate the end-of-life discussion early during their disease. Many studies have shown that most lung cancer patients admitted to ICU have not addressed their resuscitation status 21 . Reichner and colleagues 7 showed that only 26% of lung cancer patients were not-for-resuscitation on ICU admission. Recent guidelines for the management of lung cancer recommend that a palliative care team be involved with patients, family and physicians in making an end-of-life decision 22 .
Our ICU is operated under a closed system and is staffed mainly by critical care board-certified intensivists who are instrumental in discussions that lead to change in resuscitation status. A possible explanation for this involvement includes these physicians' 24-hour availability in the ICU and their sense of responsibility in maintaining or withholding life support 7 . The improvement of outcomes of lung cancer patients admitted to the ICU may be related to both a multidisciplinary approach and the better management of sepsis 19 .
The present study has several limitations, including that it was conducted at a single centre, has a selection bias of only the lung cancer patients admitted to the ICU and it cannot assess potentially significant predictors of outcome (such as the role of progressive lung disease or a reversible process such as pneumonia) because no standard protocol was followed in treating the patients. Also, most importantly, the sample size was not large. Our study also has several strengths: a full-time dedicated data collector gathered and entered our data prospectively and our unit is closed and operated OutcOme Of critically ill patients with lung cancer Anaesthesia and Intensive Care, Vol. 38, No. 5, September 2010 mainly by Critical Care Board-certified intensivists, which makes the management comparatively homogenous.
CONCLUSIONS
Our study showed that the mortality of critically ill patients admitted to the ICU with lung cancer is high. The majority of patients are for fullresuscitation on ICU admission. Intensivists are important in discussions that lead to changes in resuscitation status, and the end-of-life discussion should occur early in the course of management.
